[Fc receptor blockade in patients with chronic refractory autoimmune thrombocytopenia].
Ruiz-Argüelles
G J
GJ
Ruiz-Argüelles
A
A
Marín-López
A
A
D001327:Autoimmune Diseases / Q000628:therapy*; D002908:Chronic Disease; D004912:Erythrocytes; D006801:Humans; D007116:Immunization, Passive; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007136:Immunoglobulins; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007167:Immunotherapy; D007275:Injections, Intravenous; D009895:Opsonin Proteins / Q000627:therapeutic use*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000628:therapy*; D017452:Receptors, IgG / Q000037:antagonists & inhibitors*; D012074:Remission Induction; D018029:Rho(D) Immune Globulin
D007074:Immunoglobulin G; D007136:Immunoglobulins; D007166:Immunosuppressive Agents; D009895:Opsonin Proteins; D017452:Receptors, IgG; D018029:Rho(D) Immune Globulin